Provided herein are compositions, processes and kits for noninvasive, early determination of
fetal sex from, and/or amount of fetal nucleic acid in, an extracellular nucleic acid sample …

WO2014123580A1 - Non-platelet depleting and non-red blood cell depleting cd47
antibodies and methods of use thereof - Google Patents WO2014123580A1 - Non-platelet …

2017-10-12 Assigned to NATIONAL INSTITUTES OF HEALTH (NIH), US DEPT. OF HEALTH
AND HUMAN SERVICES (DHHS), US GOVERNMENT reassignment NATIONAL …

The invention relates to antibodies, and antigen binding fragments thereof, that specifically
bind to an epitope in the stem region of an influenza A hemagglutinin trimer and neutralize a …

First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
39682290&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

US8900590B2 - Anti-hemagglutinin antibody compositions and methods of use thereof -
Google Patents US8900590B2 - Anti-hemagglutinin antibody compositions and methods of use …

4,196,265 A 4, 1980 Koprowski et al. 4,676.980 A 6/1987 Segal et al. 4,816,567 A 3/1989
Cabilly et al. 4.946, 778 A 8, 1990 Ladner et al. 4,975,369 A 12/1990 Beaverset al …

AOJJSUZBOXZQNB-TZSSRYMLSA-N ADRIAMYCIN Chemical compound O ([C@ H] 1C
[C@@](O)(CC= 2C (O)= C3C (= O) C= 4C= CC= C (C= 4C (= O) C3= C (O) C= 21) OC) C …

Disclosed are DDR1 binding agents and methods of using the agents for treating diseases
such as cancer. The disclosure provides antibodies that specifically bind to an extracellular …

2012-04-17 Assigned to THERACLONE SCIENCES, INC. reassignment THERACLONE
SCIENCES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …